Skip to content
DataLookout
Menu

NCT07891975

Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic Nephropathy

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Primary completion date: Aug 10, 2025 to Feb 10, 2027
    • Start date: Jun 2, 2025 to Nov 7, 2026
    • Trial status changed: Completed → Not Yet Recruiting
    • Study completion date: Sep 7, 2025 to Mar 17, 2027
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

LIVER ENZYMES
Timeframe: 12 WEEKS
LIPID PROFILE (TC,TG,LDL, HDL)
Timeframe: 12 week
GLUCOSE (Fasting glucose)
Timeframe: 12 weeks
weight (kg)
Timeframe: 12 weeks

Secondary (1)

INFLAMAMATION

Arms and interventions

PLACEBO T0Placebo comparator

1 starch capsule of 300 mg along with their regular diet

1 resveratrol capsule of 300 mg per day T1Experimental

1 resveratrol capsule of 300 mg per day along with a low glycemic index diet, once a day

1 resveratrol capsules of 300 mg per day along with a low glycemic index diet, TWICE A DAY T2Experimental

1 resveratrol capsules of 300 mg per day along with a low glycemic index diet, TWICE A DAY

Dietary supplements: T0 starch capsule, T1 resveratrol capsule, T2 300 mg per day along with a low glycemic index diet, TWICE A DAY

Sites

1 site in 1 country

  • Sana NoreenLahore, Punjab Province, Pakistan